Back |
home / stock / ancn / ancn message board
Subject | By | Source | When |
---|---|---|---|
yep ... volume today ... | Timing101 | investorshub | 10/20/2020 6:02:18 PM |
Juuuust a bit of volume today :-) | Flanker7 | investorshub | 10/20/2020 4:25:22 PM |
investorshub.advfn.com/uimage/uploads/2020/7/21/qlbvdScreen Shot 2020-07- | swingingRichard | investorshub | 07/22/2020 2:54:24 AM |
Nice pop to 0.96...looks similiar drop with https://investorshub.advfn.co | 0210 | investorshub | 07/18/2020 1:08:39 PM |
Trade opp ahead...let's see what $ANCN's new mgt got. | 0210 | investorshub | 07/18/2020 12:59:57 PM |
Looking into this, what's your speculation? Unbelievable drop | FreeBird | investorshub | 07/15/2020 4:12:10 PM |
80s - hi 70s. MC $30m 50% cash, hmmmm... | 0210 | investorshub | 07/14/2020 2:14:32 PM |
A/S 100m O/S 37.1m Mkt Cap: $50m. Nasdaq | 0210 | investorshub | 06/10/2020 11:05:35 AM |
News, Short Squeeze, Breakout and More Instantly...
Chemomab Therapeutics Company Name:
ANCN Stock Symbol:
NASDAQ Market:
Chemomab Therapeutics Website:
Anchiano s hareholders approve all resolutions at shareholder meeting The merged company is expected to receive approximate gross proceeds from the private financing of $ 45 .5 million, which will be used to a dvance the Chemomab...
Are These 5 Biotech Penny Stocks Worth Watching? With the extraordinary times we live in, Covid has resulted in a large investor focus on biotech penny stocks. Within the stock market, there’s no shortage of interesting biotech companies to choose from. In 2021, it’s best ...
NEW YORK, NY / ACCESSWIRE / February 3, 2020 / Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm rated Top 50 in the 2018 and 2019 ISS Securities Class Action Services Report and headquartered at the Empire State Building in N...